Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Deficient activities of multiple steroidogenic enzymes have been reported without and with Antley-Bixler syndrome (ABS), but mutations of corresponding cytochrome P450 enzymes have not been found. We identified mutations in POR, encoding P450 oxidoreductase, the obligate electron donor for these enzymes, in a woman with amenorrhea and three children with ABS, even though knock-out of POR is embryonically lethal in mice. Mutations of POR also affect drug-metabolizing P450 enzymes, explaining the association of ABS with maternal fluconazole ingestion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“POR is located in the endoplasmic reticulum of the cells, where it operates as an electron donor for the cytochromes P450, heme oxygenase, squalene monooxygenase, and other redox partners [2,3,4].”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [3]
In the citing paper
“PORD manifests with a wide range of clinical signs and symptoms, and our study shows a broader phenotypic expression in Caucasian patients than previously observed in a large Japanese cohort (3, 7, 14, 15).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“We previously demonstrated predominant 17α-hydroxylase over 21-hydroxylase impairment by p.A287P (21), and indeed, arterial hypertension has been documented in homozygous carriers (3, 12), probably caused by excess deoxycorticosterone production as in classical 17α-hydroxylase deficiency.”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“Before our study only two p.A287P homozygous patients have been described; one with an unclear karyotype and genital appearance (7) and the other with ambiguous genitalia and 46,XY DSD (3).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
In the citing paper
“Of note, the clinical presentation of PORD shows broad phenotypic variability, with adrenal insufficiency, DSD, and skeletal malformations present in some patients but not in others (3, 7, 15, 17).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [3]
24 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., & Kim, J.-J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8411 · Cited by 744
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationThe genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Self-citationShen, A. L., O'Leary, K. A., & Kasper, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111408200 · Cited by 225
Otto, D. M. E., Henderson, C. J., Carrie, D., Davey, M., Gundersen, T. E., Blomhoff, R., Adams, R. H., Tickle, C., & Wolf, C. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6103-6116.2003 · Cited by 189
Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
Self-citationGeller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183
Self-citationPeterson, R. E., Imperato-McGinley, J., Gautier, T., & Shackleton, C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131903 · Cited by 148
Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?
Reardon, W., Smith, A., Honour, J. W., Hindmarsh, P., Das, D., Rumsby, G., Nelson, I., Malcolm, S., Adès, L., Sillence, D., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.26 · Cited by 123
Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia
Kelley, R. I., Kratz, L. E., Glaser, R. L., Netzloff, M. L., Miller Wolf, L., & Jabs, E. W. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10510 · Cited by 95
Self-citation
Research works printed but not linked: 2
- Miller, W.L. N. Engl. J. Med. 314, 1321–1322 (1986).
- Auchus, R.J. & Miller, W.L. Mol. Endocrinol. 13, 1169–1182 (1999).
Cited by
Items 101–200 of 509
Identical NR5A1 Missense Mutations in Two Unrelated 46,XX Individuals with Testicular Tissues
Igarashi, M., Takasawa, K., Hakoda, A., Kanno, J., Takada, S., Miyado, M., Baba, T., Morohashi, K.-I., Tajima, T., Hata, K., et al. (2016) · Human Mutation · doi:10.1002/humu.23116 · Cited by 66
Self-citationBiased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase
Jensen, S. B., Thodberg, S., Parween, S., Moses, M. E., Hansen, C. C., Thomsen, J., Sletfjerding, M. B., Knudsen, C., Del Giudice, R., Lund, P. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22562-w · Cited by 64
Self-citationCarey, J. C., Martinez, L. P., Balken, E., Leen‐Mitchell, M., & Robertson, J. (2008) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20533 · Cited by 69
Sheng, L., Ding, X., Ferguson, M., McCallister, M., Rhoades, R., Maguire, M., Ramesh, A., Aschner, M., Campbell, D., Levitt, P., et al. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq304 · Cited by 63
“are known to occur at appreciable frequencies in human patients (Arlt et al., 2004; Fluck et al., 2004; Fukami et al., 2005, 2006; Huang et al., 2005).”
BackgroundInfluential46,XX DSD: the masculinised female
Auchus, R. J., & Chang, A. Y. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.001 · Cited by 66
A spectrum of recessiveness among Mendelian disease variants in UK Biobank
Barton, A. R., Hujoel, M. L. A., Mukamel, R. E., Sherman, M. A., & Loh, P. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.05.008 · Cited by 64
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity
Hart, S. N., & Zhong, X.-B. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.439 · Cited by 70
“[61] first reported five missense POR mutations (A287P, R457H, V492E, C569Y, and V608F) and a splicing mutation in an initial study with four patients who had disordered steroidogenesis and Antley-Bixler syndrome.”
BackgroundElectron Transfer Partners of Cytochrome P450
Waskell, L. A., & Kim, J. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_2 · Cited by 87
“Mutations in human POR that significantly disrupt cholesterol biosynthesis and/or steroidogenesis have been shown to result in POR deficiency, characterized by Antley–Bixler syndrome and disordered steroidogenesis [108, 114].”
BackgroundFlück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.035 · Cited by 59
“The mutation C569Y, found in a patient with disordered steroidogenesis but without ABS [8], shows a higher km for NADPH, has 13% of 17,20 lyase activity, 28% of 17a-hydroxylase activity and 50% aromatase activity (Table 2).”
BackgroundResultInfluentialSelf-citationSchmidt, K., Hughes, C., Chudek, J. A., Goodyear, S. R., Aspden, R. M., Talbot, R., Gundersen, T. E., Blomhoff, R., Henderson, C., Wolf, C. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01638-08 · Cited by 61
Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis
Shackleton, C. H. L. (2012) · Lipids · doi:10.1007/s11745-011-3605-6 · Cited by 61
“Wiebke Arlt at Birmingham started to sequence this enzyme in a few patients (from various clinicians) which we had identified by metabolic profile and a year later several mutations had been found and we published a paper describing the ‘‘sixth’’ form of CAH, a condition caused by deficiency of P450 oxidoreductase [24…”
BackgroundSteroid Hormones and the Development of Reproductive Organs
Morohashi, K.-I., Baba, T., & Tanaka, M. (2012) · Sexual Development · doi:10.1159/000342272 · Cited by 65
“…in the above-mentioned genes have been found to induce abnormal male development ( StAR [Tee et al., 1995]; CYP11A1 [Katsumata et al., 2002]; HSD3B2 [Simard et al., 1994]; CYP17A1 [Kagimoto et al., 1988]; HSD17B3 [Moghrabi et al., 1998]; SRD5A2 [Andersson et al., 1991]; POR [Fluck et al., 2004]).”
Disorders of Sex Development of Adrenal Origin
Finkielstain, G. P., Vieites, A., Bergadá, I., & Rey, R. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770782 · Cited by 67
Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency
Gonçalves, J., Friães, A., & Moura, L. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000300 · Cited by 60
Adrenal cortex development and related disorders leading to adrenal insufficiency
Pignatti, E., & Flück, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111206 · Cited by 71
Self-citationBaronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
Molecular aspects of azoles-induced teratogenesis
Marotta, F., & Tiboni, G. M. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003592111 · Cited by 62
“This phenotype has been associated with missense mutations in fibroblast growth factor receptor 2 gene [119], abnormal sterol metabolism (alteration of CYP51) [120] and P450 oxidoreductase (POR) mutations, the gene encoding NADPH–CYP450 oxidoreductase [121,122].”
BackgroundClassic congenital adrenal hyperplasia and its impact on reproduction
Gomes, L. G., Bachega, T. A. S. S., & Mendonca, B. B. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.037 · Cited by 58
Self-citationIdkowiak, J., O'Riordan, S., Reisch, N., Malunowicz, E. M., Collins, F., Kerstens, M. N., Köhler, B., Graul-Neumann, L. M., Szarras-Czapnik, M., Dattani, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1607 · Cited by 64
“Interestingly, circulating androgens in our pubertal patients were relatively normal, although low androgen levels in infants and younger children with ORD are well documented (1, 2, 5).”
Self-citationDhayat, N. A., Frey, A. C., Frey, B. M., d’Uscio, C. H., Vogt, B., Rousson, V., Dick, B., & Flück, C. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.024 · Cited by 63
“The recent discovery of novel, complex steroid disorders such as P450 oxidoreductase deficiency or apparent cortisone reductase deficiency highlight the diagnostic significance of the steroid metabolome [26-28].”
BackgroundSelf-citationMarohnic, C. C., Panda, S. P., Martásek, P., & Masters, B. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607095200 · Cited by 57
P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57
Self-citationFukami, M., & Ogata, T. (2014) · Pediatrics International · doi:10.1111/ped.12518 · Cited by 56
Flück, C. E., Nicolo, C., & Pandey, A. V. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00520.x · Cited by 55
Self-citationGenetic variation in human P450 oxidoreductase
Miller, W. L., Huang, N., Agrawal, V., & Giacomini, K. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.017 · Cited by 54
Self-citationImpact of Molecular Genetics on Congenital Adrenal Hyperplasia Management
Balsamo, A., Baldazzi, L., Menabò, S., & Cicognani, A. (2010) · Sexual Development · doi:10.1159/000315959 · Cited by 54
“Since the first description of ORD [Flück et al., 2004], a wide spectrum of phenotypes have been reported.”
BackgroundInfluentialThe journey from NADPH-cytochrome P450 oxidoreductase to nitric oxide synthases
Masters, B. S. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.165 · Cited by 59
Ontogeny of adrenal steroid biosynthesis: why girls will be girls
White, P. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28296 · Cited by 53
Clinical Features of Syndromic Craniosynostosis
Rice, D. P. C. (2008) · Frontiers of oral physiology/Frontiers of oral biology · doi:10.1159/000115034 · Cited by 53
Adrenal disorders in pregnancy
Monticone, S., Auchus, R. J., & Rainey, W. E. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.155 · Cited by 58
Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
Miller, W. L. (2005) · Medical Principles and Practice · doi:10.1159/000086185 · Cited by 61
“The availability of the human POR gene sequence provided by the human genome project permitted the examination of the POR gene in this disorder. We foundPOR mutations in 3 children with ABS and abnormal steroidogenesis, and also in an adult woman with amenorrhea, hypertension, cystic ovaries and hormonal findings sugg…”
BackgroundSelf-citationThe common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0304 · Cited by 52
Self-citationMolecular Basis of Adrenal Insufficiency
Fujieda, K., & Tajima, T. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000159568.31749.4d · Cited by 51
“The POR is flavoprotein that donates electrons to all microsomal forms of cytochrome P450 (13).”
BackgroundSelf-citation46,XY Disorders of Sexual Development
Domenice, S., Arnhold, I. J. P., Costa, E. M. F., & Mendonca, B. B. (2013) · Europe PMC (PubMed Central) · Cited by 52
Linnenbaum, M., Busker, M., Kraehling, J. R., & Behrends, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035483 · Cited by 57
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Self-citationClinical and Biochemical Consequences of P450 Oxidoreductase Deficiency
Flück, C. E., & Pandey, A. V. (2011) · Endocrine Development · doi:10.1159/000321221 · Cited by 52
Self-citationKranendonk, M., Marohnic, C. C., Panda, S. P., Duarte, M. P., Oliveira, J. S., Masters, B. S. S., & Rueff, J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.014 · Cited by 60
Congenital adrenal hyperplasia: an update in children
Trapp, C. M., Speiser, P. W., & Oberfield, S. E. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328346938c · Cited by 50
Marohnic, C. C., Panda, S. P., McCammon, K. M., Rueff, J., Masters, B. S. S., & Kranendonk, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030445 · Cited by 58
Laursen, T., Singha, A., Rantzau, N., Tutkus, M., Borch, J., Hedegård, P., Stamou, D. G., Møller, B. L., & Hatzakis, N. S. (2013) · ACS Chemical Biology · doi:10.1021/cb400708v · Cited by 53
Dhayat, N. A., Dick, B., Frey, B. M., d’Uscio, C. H., Vogt, B., & Flück, C. E. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.07.009 · Cited by 54
Self-citationRestoration of mutant cytochrome P450 reductase activity by external flavin
Nicolo, C., Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.024 · Cited by 50
Self-citationHuynh, T., McGown, I. N., Cowley, D. M., Nyunt, O., Leong, G. M., Harris, M. A., & Cotterill, A. M. (2009) · PubMed Central · Cited by 60
Primary adrenal insufficiency in childhood: data from a large nationwide cohort
Capalbo, D., Moracas, C., Cappa, M., Balsamo, A., Maghnie, M., Wasniewska, M. G., Greggio, N. A., Baronio, F., Bizzarri, C., Ferro, G., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa881 · Cited by 47
Effect of Genetic Variation on Human Cytochrome P450 Reductase-Mediated Paraquat Cytotoxicity
Han, J.-F., Wang, S.-L., He, X., Liu, C.-Y., & Hong, J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj139 · Cited by 47
“Indeed, the possible effect of protein truncation on POR activity appears to be also supported by the observation of Fluck et al. (2004).”
BackgroundResultInfluentialCharacterization of the first FGFRL1 mutation identified in a craniosynostosis patient
Rieckmann, T., Zhuang, L., Flück, C. E., & Trüeb, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.006 · Cited by 45
“Similar splice site mutations have been identified in other Antley–Bixler patients at exon/intron junctions 6 and 7 [19,22].”
BackgroundInfluentialSelf-citationTee, M. K., Huang, N., Damm, I., & Miller, W. L. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0236 · Cited by 46
Self-citationZhang, X., Li, L., Ding, X., & Kaminsky, L. S. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038836 · Cited by 51
“Rare POR coding region mutations, identified in patients with Antley-Bixler syndrome and congenital adrenal hyperplasia, cause dramatic decreases in POR activity and the activities of microsomal steroidogenic P450 enzymes (Arlt et al., 2004; Flück et al., 2004; Huang et al., 2005).”
BackgroundChen, X., Pan, L. Q., Naranmandura, H., Zeng, S., & Chen, S. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038495 · Cited by 53
Fernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 49
Self-citationDean, B., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S., King, B. R., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz255 · Cited by 43
Fetal hormones and sexual differentiation
Sobel, V., Zhu, Y.-S., & Imperato-McGinley, J. (2004) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2004.08.005 · Cited by 44
“This resulted in disordered steroidogenesis and genital ambiguity in the affected male [75].”
BackgroundSubramanian, M., Agrawal, V., Sandee, D., Tam, H. K., Miller, W. L., & Tracy, T. S. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283544062 · Cited by 43
Self-citationStewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Self-citationElens, L., Nieuweboer, A. J. M., Clarke, S. J., Charles, K. A., de Graan, A. M., Haufroid, V., van Gelder, T., Mathijssen, R. H. J., & van Schaik, R. H. N. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835dc113 · Cited by 46
Udhane, S. S., Parween, S., Kagawa, N., & Pandey, A. V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00580 · Cited by 38
“Sequencing of the POR gene revealed mutations in patients with disorders of steroid biosynthesis (Flück et al., 2004; Miller et al., 2004; Pandey et al., 2004).”
BackgroundSelf-citationRoberts, C. (2020) · Journal of Developmental Biology · doi:10.3390/jdb8010006 · Cited by 51
Spectrum of Antley-Bixler Syndrome
McGlaughlin, K. L., Witherow, H., Dunaway, D. J., David, D. J., & Anderson, P. J. (2010) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e3181ec6afe · Cited by 41
“14 Further investigation has revealed the common finding of several homozygous or compound heterozygous mutations of the POR gene in many of those patients with ABS and abnormal genitalia and/or impaired steroidogenesis.(13,15,16) In the 2 patients described with ABS and abnormal genitalia and impaired steroidogenesis…”
BackgroundDiagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40
Flück, C. E., Mallet, D., Hofer, G., Samara‐Boustani, D., Léger, J., Polak, M., Morel, Y., & Pandey, A. V. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.001 · Cited by 43
“Our initial report described five missense mutations (A287P, R457H, V492E, C569Y, and V608F) identified in four patients [1] and the later study added the mutants/polymorphisms A115V, T142A, Q153R, P228L, M263V, R316W, G413S, Y459H, A503V, G539R, L565P, R616X,”
BackgroundMethodInfluentialSelf-citationNovel Insight into Etiology, Diagnosis and Management of Primary Adrenal Insufficiency
Malikova, J., & Flück, C. E. (2014) · Hormone Research in Paediatrics · doi:10.1159/000363107 · Cited by 40
Self-citationImpact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase
Flück, C. E., & Pandey, A. V. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.031 · Cited by 43
“Similar to other P450 in endoplasmic reticulum, CYP17A1 requires POR for its activities [1,15].”
InfluentialSelf-citationParween, S., DiNardo, G., Baj, F., Zhang, C., Gilardi, G., & Pandey, A. V. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105507 · Cited by 39
Self-citationSignaling Mechanisms Underlying Genetic Pathophysiology of Craniosynostosis
Wu, X., & Gu, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29183 · Cited by 39
“Such mutations are associated with Antley-Bixler syndrome [70].”
BackgroundPandey, A. V., Flück, C. E., Huang, N., Tajima, T., Fujieda, K., & Miller, W. L. (2004) · Endocrine Research · doi:10.1081/erc-200044134 · Cited by 39
Self-citationWang, S., Han, J., He, X., Wang, X., & Hong, J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011056 · Cited by 39
“In contrast, the expressed C569Y variant protein was reported to show an activity decrease in cytochrome c reduction in two previous studies (Arlt et al., 2004; Fluck et al., 2004).”
BackgroundMethodResultInfluentialYazawa, T., Imamichi, Y., Sekiguchi, T., Miyamoto, K., Uwada, J., Khan, M. R. I., Suzuki, N., Umezawa, A., & Taniguchi, T. (2019) · BioMed Research International · doi:10.1155/2019/8973076 · Cited by 44
Recruitment of governing elements for electron transfer in the nitric oxide synthase family
Jáchymová, M., Martasek, P., Panda, S. P., Roman, L. J., Panda, M., Shea, T. M., Ishimura, Y., Kim, J. J., & Masters, B. S. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506522102 · Cited by 42
Parween, S., Roucher-Boulez, F., Flück, C. E., Lienhardt-Roussie, A., Mallet, D., Morel, Y., & Pandey, A. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1928 · Cited by 37
“The 17 -hydroxylase and 17,20-lyase activities of CYP17A1 were assayed using (14)C progesterone and (3)H 17-OH pregnenolone as substrates for the 17 -hydroxylase reaction and the 17,20-lyase reaction, respectively (2).”
BackgroundMethodInfluentialSelf-citationP450 oxidoreductase deficiency
Miller, W. L., Huang, N., Flück, C. E., & Pandey, A. V. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17344-3 · Cited by 37
Self-citationBarbaro, M., Wedell, A., & Nordenström, A. (2011) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2011.01.001 · Cited by 40
Adrenal androgens, adrenarche, and zona reticularis: A human affair?
Dumontet, T., & Martinez, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111239 · Cited by 44
Pandey, A. V., Flück, C. E., & Mullis, P. E. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.072 · Cited by 36
Self-citationAge-specific changes in sex steroid biosynthesis and sex development
Krone, N., Hanley, N. A., & Arlt, W. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.06.001 · Cited by 36
Self-citationUpdate on Adrenarche—Still a Mystery
Augsburger, P., Liimatta, J., & Flück, C. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae008 · Cited by 48
Self-citationGuidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 40
“Virilization of the external genitalia develops in 46,XX girls with POR deficiency, while incomplete virilization in 46,XY boys with POR deficiency is frequently associated with early craniosynostosis, characteristic facies, humeral-radial synostosis, and joint contracture (69, 70).”
BackgroundSelf-citationYim, S.-K., Jung, H.-C., Pan, J., Kang, H., Ahn, T., & Yun, C. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.05.013 · Cited by 37
“It was found that CPR-deWcient individuals have a broad range of disorders, from infants with congenital malformations to women with the polycysic ovary syndrome [13–15].”
BackgroundCytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
Serafi, I. E., Afsharian, P., Moshfegh, A., Hassan, M., & Terelius, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141979 · Cited by 39
Translating genomics to the clinical diagnosis of disorders/differences of sex development
Parivesh, A., Barseghyan, H., Délot, E. C., & Vilain, E. J. N. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2019.01.005 · Cited by 39
The classic and nonclassic concenital adrenal hyperplasias
Auchus, R. J. (2015) · Endocrine Practice · doi:10.4158/ep14474.ra · Cited by 35
Li, H., Zhao, A., Xie, M., Chen, L., Wu, H., Shen, Y., & Wang, H. (2021) · Translational Pediatrics · doi:10.21037/tp-21-499 · Cited by 36
“The pathogenesis of ABS is complicated and often influenced by genetic heterogeneity, including mutations in fibroblast growth factor receptor 2 (FGFR2) mutation and cytochrome P450 oxidoreductase (POR) (4-6).”
BackgroundKranc, W., Brązert, M., Ożegowska, K., Nawrocki, M. J., Budna, J., Celichowski, P., Dyszkiewicz-Konwińska, M., Jankowski, M., Ješeta, M., Pawelczyk, L. A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122673 · Cited by 37
“Defects in POR genes have been proven to cause a variety of symptoms, from embryonic lethality to disordered steroidogenesis, congenital adrenal hyperplasia, ambiguous genitalia, and Antley-Bixler syndrome [26,28,29].”
BackgroundJu, Y., Mizutani, T., Imamichi, Y., Yazawa, T., Matsumura, T., Kawabe, S., Kanno, M., Umezawa, A., Kangawa, K., & Miyamoto, K. (2012) · Endocrinology · doi:10.1210/en.2012-1334 · Cited by 37
“The importance of the electron-transfer system in steroidogenesis is also demonstrated by P450 oxidoreductase (POR), a microsomal enzyme that transfers electrons to various P450 steroidogenic enzymes, involvement in steroidogenesis as an SF-1-target gene (32), and mutations in the POR gene or deletion of the POR promo…”
BackgroundWitchel, S. F., & Topaloglu, A. K. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00017-2 · Cited by 35
Bai, Y., Li, J., & Wang, X. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0312-9 · Cited by 34
“These syntheses and conversions depend on CYP17A1, CYP19A1, CYP21A2, which require POR [8, 9].”
InfluentialWang, K., Peng, X., Zuo, Y., Li, Y., & Chen, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154633 · Cited by 35
“Since the first report of CPR deficiency [26], many studies worldwide have described the varying phenotypes in humans; to date, over 2,000 single nucleotide polymorphisms (SNPs) have been described in human CPR genes, encompassing over 150 missense mutations that affect transcription, have also been identified in many…”
BackgroundOrchestrated Domain Movement in Catalysis by Cytochrome P450 Reductase
Freeman, S. L., Martel, A., Raven, E. L., & Roberts, G. C. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-09840-8 · Cited by 34
Janner, M., Flück, C. E., & Mullis, P. E. (2012) · Hormone Research in Paediatrics · doi:10.1159/000341585 · Cited by 36
Self-citationAchermann, J. C., & Hughes, I. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00023-7 · Cited by 40
POR R457H is a global founder mutation causing Antley–Bixler syndrome with autosomal recessive trait
Adachi, M., Asakura, Y., Matsuo, M., Yamamoto, T., Hanaki, K., & Arlt, W. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31112 · Cited by 34
Self-citationMcCammon, K. M., Panda, S. P., Xia, C., Kim, J.-J. P., Moutinho, D., Kranendonk, M., Auchus, R. J., Lafer, E. M., Ghosh, D., Martasek, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716019 · Cited by 33
“sexual ambiguities in these patients (9, 10), was due to the inherent properties of this variant affecting its interactions with these particular steroidogenic CYPs.”
BackgroundInfluentialCytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33
Self-citationElectron Transfer Pathways in Cholesterol Synthesis
Porter, T. D. (2015) · Lipids · doi:10.1007/s11745-015-4065-1 · Cited by 34
“Not until 2004 was it clearly demonstrated that this unusual form of CAH was due to a genetic defect in cytochrome P450 reductase [31].”
BackgroundPolymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy
Gong, L., Zhang, C., Lv, J., Zhou, H., & Fan, L. (2017) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000297 · Cited by 35
Steroidogenesis in Aldosterone-Producing Adenoma Revisited by Transcriptome Analysis
Assié, G., Auzan, C., Gasc, J., Baviéra, E. E., Balaton, A. J., Elalouf, J., Jeunemaître, X., Plouin, P., Corvol, P. L., & Clauser, É. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1309 · Cited by 35
Papadakis, G. E., Dumont, A., Bouligand, J., Chasseloup, F., Raggi, A., Catteau-Jonard, S., Boute‐Bénéjean, O., Pitteloud, N., Young, J., & Dewailly, D. (2020) · Human Reproduction · doi:10.1093/humrep/deaa020 · Cited by 38
Kumar, R., Jayaraman, M., Ramadas, K., & Chandrasekaran, A. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107708 · Cited by 34
Nomenclature for alleles of the cytochrome P450 oxidoreductase gene
Sim, S. C., Miller, W. L., Zhong, X.-B., Arlt, W., Ogata, T., Ding, X., Roland Wolf, C., Flück, C. E., Pandey, A. V., Henderson, C. J., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832af5b7 · Cited by 31
Self-citation
Metadata
- Authors
- Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Hokkaido University (JP)
- Sydney Children's Hospital (AU)
- Johns Hopkins University (US)
- Asahikawa Medical University (JP)
- Corresponding author
- Miller, Walter L
- Venue
- Nature Genetics
- Published
- 2004-02-01
- Volume
- 36
- Issue
- 3
- Pages
- 228-230
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1988067304
- Semantic Scholar
- de46a6781c9fe47ed0dcc705d3a243d3ba41bef5
- Cited by
- 509
- References
- 14
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 16 · 2023: 15 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 15 · 2017: 24 · 2016: 22 · 2015: 24 · 2014: 19 · 2013: 28 · 2012: 21
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- National Research Foundation
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- Antley-Bixler syndrome, cytochrome P450 oxidoreductase, POR gene, steroidogenesis disorders, amenorrhea, fluconazole, drug metabolism, congenital disorders of sex development
- MeSH terms
- Craniosynostoses, Female, Humans, Ketone Oxidoreductases, Mutation, NADPH-Ferrihemoprotein Reductase, Gonadal Steroid Hormones, Syndrome, Synostosis, Pyruvate Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.